Investing Profile

Klaus Veitinger

InvestorVC
Venture Partner at Orbimed
orbimed.comNew York, New York
Photo of Klaus Veitinger, Venture Partner at OrbiMed

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
OrbiMed Venture Partner
$1M - $75.0M
$4.0M
4
$18B
CompanyStageDateRound SizeTotal Raised
Neurogastrx
Series BAug 2021$60M
Series AJan 2018$45M
$110M
Co-investors: David Allison (Westlake Village BioPartners), Aaron Royston (venBio)
Sparrow Pharmaceuticals
Series AMay 2021$50M
$50M
Promentis Pharmaceuticals
Series CMar 2017$26M
$26M